Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

Development of mechanism-based therapeutics for Amyotrophic Lateral Sclerosis (ALS)

   Department of Clinical Biochemistry and Pharmacology

   Applications accepted all year round  Funded PhD Project (Students Worldwide)

About the Project

The laboratory of Prof. Stanislav Engel ( looks for a highly motivated student to take part in the research, whose aims are to decipher the molecular mechanism of neurodegenerative diseases, in particular Amyotrophic Lateral Sclerosis (ALS), the most common motor neuron disease, and develop novel mechanism-based therapeutic approached to combat them. The research combines the use of transgenic animals, viral vectors for targeting the therapeutic agents to the CNS and active immunization strategy using mRNA technology.

We welcome an outstanding international student (including a refugee) with an M.Sc. in life sciences or similar disciplines to apply for PhD studies and join the lab.

The Engel’s lab belongs to the Clinical Biochemistry and Pharmacology Department of the Ben-Gurion University (BGU) Medical School (, which is a prominent research and teaching university in Israel. Ph.D. program lasts four years, during which the students receive full fellowships. Dormitory nearby the campus is an option.

The scientific environment at the BGU is dynamic and collaborative, and the University has a large and supportive community of international students. Beer Sheva, where the BGU is located, is the biggest city of South Israel, cultural and technological center, and is located 40 min driving from the Mediterranean Sea, and 1 h driving from the Dead Sea.

To apply: please send a letter describing your research experience and interests, and a CV (including transcripts) to Prof. Stanislav (Stas) Engel ().

Biological Sciences (4)

Register your interest for this project